NDC 63304-506
pentazocine and naloxone
Pentazocine And Naloxone
pentazocine and naloxone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is Pentazocine; Naloxone Hydrochloride.
| Product ID | 63304-506_48ee2bd7-f7c9-4bf8-8932-ba9065c64cf3 |
| NDC | 63304-506 |
| Product Type | Human Prescription Drug |
| Proprietary Name | pentazocine and naloxone |
| Generic Name | Pentazocine And Naloxone |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-07-31 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA075523 |
| Labeler Name | Sun Pharmaceutical Industries, Inc. |
| Substance Name | PENTAZOCINE; NALOXONE HYDROCHLORIDE |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| Pharm Classes | Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |